Favipiravir 200 mg (Paxlovid)

Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective).
Favigan is approved for manufacture and sale in Japan as an influenza antiviral. It selectively inhibits the RNA polymerase of the influenza virus, an enzyme required for viral replication once human host cells are infected. COVID-19 also uses this enzyme to replicate and is classified into the same type of single-stranded RNA virus as influenza; hence, it is believed that Favigan may be effective in treating COVID-19.
Add to wishlist
Share

    Favipiravir INN is the active ingredient of the antiviral drug Favipiravir 200 mg. Favipiravir was first created to treat new or re-emerging influenza viruses, but it has drawn a lot of interest due to its possible use in treating viral infections, especially RNA viruses like SARS-CoV-2, the virus that causes COVID-19. Favipiravir 200 mg is produced following strict quality standards to guarantee safety, efficacy, and dependability. It is designed to satisfy the increasing demand for antiviral assistance in clinical settings.


    Mechanism of Action

    Favipiravir functions by specifically blocking RNA viruses’ RNA-dependent RNA polymerase (RdRp). The reproduction of viruses depends on this enzyme. Favipiravir helps control the infection and lower the viral load by blocking RdRp, which prevents the virus from multiplying inside the host cells. It is a broad-spectrum antiviral medication that works against a variety of RNA viruses because of this mechanism.


    Indications

    The main indications for Favipiravir 200 mg are:

     

    treatment of mild to severe instances of COVID-19, especially when started early in the infection’s progression.

     

    control of some influenza strains and other diseases linked to the RNA virus (as approved by the appropriate health authorities).

     

    A healthcare provider should always provide guidance when using this medicine, and it should be based on local regulatory approvals as well as current clinical guidelines.


    Dosage and Administration

    The standard dosage for adults (for COVID-19 or as prescribed by a doctor) is:

     

    First day: 1800 mg twice a day (3600 mg total)

     

    800 mg twice a day starting on day two

     

    Duration: Usually 7–14 days, contingent on clinical judgment and severity

     

    Tablets can be taken with or without food, and they should be swallowed whole with water. To guarantee the best possible antiviral efficacy, the recommended dosage must be followed.


    Contraindications

    Favipiravir should not be used in:

     

    Individuals who have a history of hypersensitivity to Favipiravir or any of the formulation’s ingredients.

     

    Ladies who are pregnant or who may be pregnant.

     

    those with significant liver damage (unless closely monitored by a physician).


    Warnings and Precautions

    Because favipiravir is teratogenic, it should not be used during pregnancy or lactation. Both men and women should use effective contraception while undergoing therapy and for a while following.

    Liver and Renal Function: Throughout treatment, liver enzymes and renal function should be checked on a regular basis.

    Favipiravir may raise uric acid levels; therefore, use it with caution if you have gout or hyperuricemia.

    Before beginning treatment, always get advice from a healthcare professional, particularly for people who already have health issues.


    Adverse Effects

    Typical adverse effects could include:

     

    elevated ALT and AST levels in the liver

     

    elevated levels of uric acid, or hyperuricemia

     

    Having diarrhea

     

    Feeling queasy

     

    Discomfort in the abdomen

     

    When stopped, the majority of side effects are reversible and mild to moderate in intensity. Although severe side effects are uncommon, they should be reported to a healthcare professional right away.


    Drug Interactions

    Other drugs that may interact with favipiravir include:

     

    Medications that alter liver enzymes

     

    Immunosuppressive Drugs

     

    Additional antiviral drugs

     

    To prevent any drug interactions, the healthcare provider should be informed of the full list of current drugs.


    Storage Conditions

    Store below 30°C in a dry place.

     

    Protect against light and moisture.

     

    Don’t let kids get to it.


    Packaging

    Usually, Favipiravir 200 mg is offered in:

     

    blisters containing ten to fifteen pills

     

    boxed packaging with a booklet with patient information

     

    Depending on market and legal needs, packaging may change.


    Conclusion

    Favipiravir 200 mg is an antiviral medication with scientific support that is intended to successfully treat RNA virus infections. It is a valuable tool in the treatment toolbox for illnesses like COVID-19 because of its shown ability to stop viral proliferation and its controllable safety profile. Like any prescription medication, patients should be periodically checked while receiving treatment, and medical practitioners should provide guidance on how to utilize it.

     

    Review your healthcare professional or review the official prescribing information for any further information or clinical advice.


    Order Now At Mdx Pharma bd….

    To order from MDX Pharma BD, visit their website at https://mdxpharmabd.com, where you can browse products and place orders online. For inquiries or orders via email, contact emedicarepharma@gmail.com. Alternatively, call (+88) 01929123476. Their address is 29, Abdullahpur, Uttara, Dhaka-1230, Bangladesh.

     

    1. What is the purpose of 200 mg of Favipiravir?
    Favipiravir, an antiviral medication found in Favipiravir 200 mg, is mostly used to treat mild to moderate COVID-19 infections and occasionally influenza. It aids in preventing some RNA viruses from replicating.

     

    2. Favipiravir: How does it work?
    Favipiravir functions by preventing viruses’ RNA-dependent RNA polymerase enzyme, which is necessary for viral reproduction, from functioning. This reduces how quickly the infection spreads throughout the body.

     

    3. What dosage of 200 mg of Favipiravir is advised?
    Normal dosage for treating COVID-19:
    Day 1: 1600 mg twice a day (a total of 8 pills).
    Days 2–14: three tablets twice a day, 600 mg twice a day
    Always heed your doctor’s advice, though, as dosages can change depending on a patient’s health and condition.

     

    4. Is Favipiravir safe for women who are nursing or pregnant?
    Because favipiravir may harm the fetus or baby, it is not advised to use it during pregnancy or nursing. Effective contraception should be used by women of reproductive age both during and after treatment.

     

    5. Can Favipiravir be used in severe COVID-19 cases?
    Favipiravir is usually prescribed for mild to moderate COVID-19. For severe cases, other treatment protocols (e.g., corticosteroids, monoclonal antibodies, antivirals like remdesivir) may be preferred.

    Generic Name:

    Favipiravir INN

    Theraputic Category:

    Others

    Pack Size:

    5×8's